146 related articles for article (PubMed ID: 21171993)
1. Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study.
Chapman SJ; Khor CC; Vannberg FO; Rautanen A; Walley A; Segal S; Moore CE; Davies RJ; Day NP; Peshu N; Crook DW; Berkley JA; Williams TN; Scott JA; Hill AV
Crit Care; 2010; 14(6):R227. PubMed ID: 21171993
[TBL] [Abstract][Full Text] [Related]
2. NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations.
Chapman SJ; Khor CC; Vannberg FO; Rautanen A; Segal S; Moore CE; Davies RJ; Day NP; Peshu N; Crook DW; Berkley JA; Williams TN; Scott JA; Hill AV
Genes Immun; 2010 Jun; 11(4):319-25. PubMed ID: 19798075
[TBL] [Abstract][Full Text] [Related]
3. IkappaB genetic polymorphisms and invasive pneumococcal disease.
Chapman SJ; Khor CC; Vannberg FO; Frodsham A; Walley A; Maskell NA; Davies CW; Segal S; Moore CE; Gillespie SH; Denny P; Day NP; Crook DW; Davies RJ; Hill AV
Am J Respir Crit Care Med; 2007 Jul; 176(2):181-7. PubMed ID: 17463416
[TBL] [Abstract][Full Text] [Related]
4. Mannose-binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children.
Lundbo LF; Harboe ZB; Clausen LN; Hollegaard MV; Sørensen HT; Hougaard DM; Konradsen HB; Nørgaard M; Benfield T
Clin Infect Dis; 2014 Aug; 59(4):e66-71. PubMed ID: 24771334
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation in NFKBIE Is Associated With Increased Risk of Pneumococcal Meningitis in Children.
Lundbo LF; Harboe ZB; Clausen LN; Hollegaard MV; Sørensen HT; Hougaard DM; Konradsen HB; Nørgaard M; Benfield T
EBioMedicine; 2016 Jan; 3():93-99. PubMed ID: 26870821
[TBL] [Abstract][Full Text] [Related]
6. Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.
Lingappa JR; Dumitrescu L; Zimmer SM; Lynfield R; McNicholl JM; Messonnier NE; Whitney CG; Crawford DC
PLoS One; 2011; 6(8):e23413. PubMed ID: 21858107
[TBL] [Abstract][Full Text] [Related]
7. MBL genotype and risk of invasive pneumococcal disease: a case-control study.
Roy S; Knox K; Segal S; Griffiths D; Moore CE; Welsh KI; Smarason A; Day NP; McPheat WL; Crook DW; Hill AV;
Lancet; 2002 May; 359(9317):1569-73. PubMed ID: 12047967
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase 2A (NOS2A) polymorphisms are not associated with invasive pneumococcal disease.
Payton A; Payne D; Mankhambo LA; Banda DL; Hart CA; Ollier WE; Carrol ED
BMC Med Genet; 2009 Mar; 10():28. PubMed ID: 19309520
[TBL] [Abstract][Full Text] [Related]
9. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection.
Yuan FF; Wong M; Pererva N; Keating J; Davis AR; Bryant JA; Sullivan JS
Immunol Cell Biol; 2003 Jun; 81(3):192-5. PubMed ID: 12752683
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection.
Yuan FF; Marks K; Wong M; Watson S; de Leon E; McIntyre PB; Sullivan JS
Immunol Cell Biol; 2008; 86(3):268-70. PubMed ID: 18180796
[TBL] [Abstract][Full Text] [Related]
11. TLR2-TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae.
Tellería-Orriols JJ; García-Salido A; Varillas D; Serrano-González A; Casado-Flores J
Med Intensiva; 2014; 38(6):356-62. PubMed ID: 24144680
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease.
Chapman SJ; Vannberg FO; Khor CC; Segal S; Moore CE; Knox K; Day NP; Davies RJ; Crook DW; Hill AV
Mol Immunol; 2007 May; 44(12):3267-70. PubMed ID: 17382393
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to invasive pneumococcal disease.
Sangil A; Arranz MJ; Güerri-Fernández R; Pérez M; Monzón H; Payeras A; Andrés M; Torviso J; Ibañez L; Garau J; Calbo E
Infect Genet Evol; 2018 Apr; 59():126-131. PubMed ID: 29407193
[TBL] [Abstract][Full Text] [Related]
14. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.
Ndila CM; Uyoga S; Macharia AW; Nyutu G; Peshu N; Ojal J; Shebe M; Awuondo KO; Mturi N; Tsofa B; Sepúlveda N; Clark TG; Band G; Clarke G; Rowlands K; Hubbart C; Jeffreys A; Kariuki S; Marsh K; Mackinnon M; Maitland K; Kwiatkowski DP; Rockett KA; Williams TN;
Lancet Haematol; 2018 Aug; 5(8):e333-e345. PubMed ID: 30033078
[TBL] [Abstract][Full Text] [Related]
15. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis.
Brouwer MC; de Gans J; Heckenberg SG; Zwinderman AH; van der Poll T; van de Beek D
Lancet Infect Dis; 2009 Jan; 9(1):31-44. PubMed ID: 19036641
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases.
Bouglé A; Max A; Mongardon N; Grimaldi D; Pène F; Rousseau C; Chiche JD; Bedos JP; Vicaut E; Mira JP
Chest; 2012 Dec; 142(6):1474-1481. PubMed ID: 22628489
[TBL] [Abstract][Full Text] [Related]
17. Host genetic variability and pneumococcal disease: a systematic review and meta-analysis.
Kloek AT; Brouwer MC; van de Beek D
BMC Med Genomics; 2019 Sep; 12(1):130. PubMed ID: 31519222
[TBL] [Abstract][Full Text] [Related]
18. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
19. Fcgamma-receptor IIA genotype and invasive pneumococcal infection.
Moens L; Van Hoeyveld E; Verhaegen J; De Boeck K; Peetermans WE; Bossuyt X
Clin Immunol; 2006 Jan; 118(1):20-3. PubMed ID: 16150646
[TBL] [Abstract][Full Text] [Related]
20. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.
Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K
AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
